The House of Representatives last night voted 234-183 to pass legislation (H.R. 987) that combines several AHA-supported bills to help lower prescription drug costs and strengthen the Affordable Care Act’s health insurance marketplaces. The legislation’s drug-related provisions would allow generic drug manufacturers facing certain anticompetitive delay tactics to bring an action in federal court for injunctive relief, and help decrease the time it takes for generic competitors to get to market. The ACA marketplace provisions would provide funding to expand navigator support and outreach to help consumers enroll in individual market coverage, and void a final rule that expanded short-term limited duration health plans. 
 

Related News Articles

Headline
The AHA, joined by America’s Essential Hospitals, Association of American Medical Colleges, and Federation of American Hospitals today urged the Supreme Court…
Headline
The Centers for Medicare & Medicaid Services next month will begin collecting and distributing risk adjustment payments in the permanent risk adjustment…
Headline
The Affordable Care Act requires the federal government to pay insurers the full amount of their losses under the temporary Risk Corridors Program and insurers…
Headline
List prices for branded pharmaceutical products in the United States increased 159% between 2007 and 2018, an average of 9.1% per year, according to a study…
Headline
The Supreme Court today said it will review, during its term beginning in October, a federal appeals court decision that held the Affordable Care Act's…
Headline
Four drugs used in hospitals for years increased their prices between 525% and 1,644% after receiving formal approval through the Food and Drug Administration’…